PRESS RELEASE published on 03/04/2025 at 15:36, 1 year 6 months ago Form 8.3 - The Vanguard Group, Inc.: Direct Line Insurance Group plc The Vanguard Group, Inc. disclosed a 5.38% ownership stake in Direct Line Insurance Group plc. Additional disclosures included dealings of 10 10/11p ordinary securities Securities Vanguard Group Dealings Ownership Stake Direct Line Insurance
BRIEF published on 03/03/2025 at 16:30, 1 year 6 months ago The Vanguard Group Discloses Position in Direct Line Insurance The Vanguard Group Takeover Code Securities Trading Form 8.3 Disclosure Direct Line Insurance
BRIEF published on 03/03/2025 at 16:30, 1 year 6 months ago Le groupe Vanguard dévoile sa position dans Direct Line Insurance Code De Prise De Contrôle Le Groupe Vanguard Négoce De Titres Divulgation Du Formulaire 8.3 Assurance Ligne Directe
PRESS RELEASE published on 03/03/2025 at 16:25, 1 year 6 months ago Form 8.3 - The Vanguard Group, Inc.: Direct Line Insurance Group plc The Vanguard Group, Inc. discloses a 5.37% stake in Direct Line Insurance Group plc. The disclosure was made on 03 March 2025 under Form 8.3 Form 8.3 Vanguard Group Inc. Stake Disclosure Financial Holdings Direct Line Insurance Group Plc
BRIEF published on 02/28/2025 at 15:11, 1 year 6 months ago Vanguard Group Discloses Stake in Direct Line Insurance Group Securities Disclosure Stake Vanguard Direct Line
BRIEF published on 02/28/2025 at 15:11, 1 year 6 months ago Le groupe Vanguard révèle sa participation dans Direct Line Insurance Group Titres Divulgation Avant-garde Miser Ligne Directe
PRESS RELEASE published on 02/28/2025 at 15:06, 1 year 6 months ago Form 8.3 - The Vanguard Group, Inc.: Direct Line Insurance Group plc The Vanguard Group, Inc. discloses a 5.38% ownership in Direct Line Insurance Group plc. Additional disclosures include a purchase of 15,862 securities at 2.80 GBP per unit on 27 Feb 2025 Vanguard Group Ownership Disclosure Securities Purchase Direct Line Insurance GBP
BRIEF published on 02/27/2025 at 15:17, 1 year 6 months ago Vanguard Group Discloses Position in Direct Line Insurance Group Form 8.3 Takeover Code Securities Disclosure Vanguard Group Direct Line Insurance
BRIEF published on 02/27/2025 at 15:17, 1 year 6 months ago Le groupe Vanguard révèle sa position dans Direct Line Insurance Group Groupe Vanguard Code De Prise De Contrôle Formulaire 8.3 Divulgation Des Valeurs Mobilières Assurance Ligne Directe
PRESS RELEASE published on 02/27/2025 at 15:12, 1 year 6 months ago Form 8.3 - The Vanguard Group, Inc.: Direct Line Insurance Group plc The Vanguard Group, Inc. discloses a 5.38% interest in Direct Line Insurance Group plc. Additional disclosure includes dealings in securities Form 8.3 Securities Disclosure Vanguard Group Dealings Direct Line Insurance
Published on 09/11/2026 at 04:00, 7 hours 23 minutes ago Torq Announces Debt Settlement and Corporate Update
Published on 09/10/2026 at 22:25, 12 hours 58 minutes ago Pathfinder Ventures Announces Appointment of Mickey Perret as Chief Executive Officer
Published on 09/10/2026 at 15:20, 20 hours 3 minutes ago MicroVision to Preview Next-Generation Lidar-Based Perception Platform at IAA Transportation 2026
Published on 09/10/2026 at 15:00, 20 hours 23 minutes ago All Randomized Pediatric Patients to Continue in the Single-Blind Extension Phase of Jaguar Health's Pivotal Clinical Trial of Crofelemer for Microvillus Inclusion Disease (MVID) with Intestinal Failure (IF)
Published on 09/11/2026 at 10:15, 1 hour 8 minutes ago TCMA Receives Two National Awards, Highlighting Thailand’s Cement Industry Progress Towards Net Zero 2050
Published on 09/11/2026 at 09:20, 2 hours 3 minutes ago Cantourage Expands Portfolio with New Cannabis Active Ingredients for Innovative Compounded Medicines
Published on 09/11/2026 at 09:05, 2 hours 18 minutes ago ROHM's New High Anti-surge Chip Resistors in "SDR01 Series" Achieve 0.33W Rated Power in 0402 Size
Published on 09/11/2026 at 09:00, 2 hours 23 minutes ago Homann Holzwerkstoffe publishes its 2026 half-year report
Published on 09/11/2026 at 07:00, 4 hours 23 minutes ago Transparantiekennisgeving van Baltisse Groep
Published on 09/11/2026 at 07:00, 4 hours 23 minutes ago BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/11/2026 at 07:00, 4 hours 23 minutes ago BIOPHYTIS ANNONCE LA RÉALISATION D’UNE AUGMENTATION DE CAPITAL DE 5,3 MILLIONS D’EUROS DESTINÉE À FINANCER SON ESSAI DE PHASE 2 DANS L’OBÉSITÉ
Published on 09/10/2026 at 19:30, 15 hours 53 minutes ago Availability of the 2026 Interim Financial Report
